Valuation: DexCom, Inc.

Market Cap 32.47B 164B 28.94B 26.81B 24.38B 45.74B 3,078B 46.49B 322B 126B 1,609B 122B 119B 5,143B P/E 2026 *
34.6x
P/E 2027 * 29.1x
Enterprise Value 31.71B 160B 28.26B 26.18B 23.81B 44.67B 3,006B 45.4B 314B 123B 1,571B 119B 116B 5,023B EV / Sales 2026 *
6.06x
EV / Sales 2027 * 5.42x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-7.95%
1 week-2.06%
Current month-3.92%
1 month-5.82%
3 months+17.88%
6 months+33.28%
Current year+14.42%
1 week 8.57
Extreme 8.57
8.75
1 month 8.16
Extreme 8.16
9.22
Current year 5.75
Extreme 5.75
9.57
1 year 5.75
Extreme 5.75
9.57
3 years 5.75
Extreme 5.75
14.45
5 years 5.75
Extreme 5.75
18.3
10 years 5.75
Extreme 5.75
18.3
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-7.95%-2.06% - - 32.47B
-0.79%+2.20%-19.65%+9.03% 181B
-2.09%+0.91%-3.28%+28.22% 116B
+1.11%+5.43%-21.85%+11.00% 113B
-1.52%+3.89%-51.34%-7.07% 79.83B
-0.27%+4.60%+3.85%+79.05% 65.06B
-0.27%+2.10%+15.54%+66.81% 54.35B
-0.53%+0.98%-0.14%-25.92% 52.23B
-0.81%+6.08%-13.62%+30.57% 44.15B
-0.07%+0.07%+25.65%-0.07% 32.47B
Average -1.32%+5.18%-7.20%+21.29% 82.07B
Weighted average by Cap. -0.96%+5.50%-12.45%+19.44%

Financials

2026 *2027 *
Net sales 5.23B 26.44B 4.66B 4.32B 3.93B 7.37B 496B 7.49B 51.79B 20.37B 259B 19.62B 19.21B 828B 5.79B 29.29B 5.16B 4.78B 4.35B 8.16B 549B 8.3B 57.38B 22.56B 287B 21.73B 21.28B 918B
Net income 973M 4.92B 867M 803M 731M 1.37B 92.25B 1.39B 9.64B 3.79B 48.22B 3.65B 3.57B 154B 1.15B 5.79B 1.02B 946M 860M 1.61B 109B 1.64B 11.35B 4.46B 56.77B 4.3B 4.21B 181B
Net Debt -761M -3.85B -678M -629M -571M -1.07B -72.16B -1.09B -7.54B -2.96B -37.72B -2.86B -2.8B -121B -1.06B -5.37B -946M -877M -797M -1.5B -101B -1.52B -10.51B -4.13B -52.6B -3.98B -3.9B -168B
Projected Income Statement - Annual - DexCom, Inc.
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-10-19 R$8.570 -7.95% 5
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - DexCom, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
86.04USD
Average target price
96.46USD
Spread / Average Target
+12.11%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DexCom, Inc.